摘要：

The invention relates to pharmaceutical formulations comprising human growth hormone, an amino acid selected from the group of Asp, Ile, Val, Leu or His, or a derivative of histidine and a non-ionic detergent, eg. polysorbate or poloxamer. The formulation is stabilized against deamidation and aggregation. The formulation may be an aqueous formulation.

展开